Skip to content

Effectiveness of Behavioral Activation and Metacognitive Therapy on Depression, Anxiety, and Cognitive emotion regulation strategies

Effectiveness of Behavioral Activation and Metacognitive Therapy on Depression, Anxiety, and Cognitive emotion regulation strategies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013030912753N1
Enrollment
41
Registered
2013-03-17
Start date
2011-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression and Anxiety. Depressive episode, Phobic anxiety disorders, Other anxiety disorders

Interventions

Intervention 1: Carrying out 8 sessions of group Behavioral Activation therapy that executed weekly and 90 minutes.Behavioral Activation adapted from Dimidjian,Martell, Addis, & Herman-Dunn (2008) and
Behavior
Treatment - Other
Carrying out 8 sessions of group Behavioral Activation therapy that executed weekly and 90 minutes.Behavioral Activation adapted from Dimidjian,Martell, Addis, & Herman-Dunn (2008) and Martell, Dimidj
Carrying out 8 sessions of Metacognitive Therapy that executed weekly and 90 minutes. Metacognitive Therapy conducted according to Metacognitive Therapy for anxiety and depressive disorders manual (We
Control Group (without intervention)

Sponsors

Shahid Chamran University of Ahvaz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: acquisition of more than 19 scores on Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI), confirmation of presence comorbid depression and anxiety according to Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I); not receiving any psychological or pharmaceutic therapies (one year before than starting research at least); having minimum 18 and maximum 30 years old; being bachelor student. Exclusion Criteria: having psychotic disorder or depressive disorders with psychotic features; presence of personality disorder according to Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II) physical illness or medical conditions underlying depression; suicidal ideations; substance abusing.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Pretest, Posttest, Follow up. Method of measurement: Beck Depression Inventory.;Anxiety. Timepoint: Pretest, Posttest, Follow up. Method of measurement: Beck Anxiety Inventory.;Cognitive emotion regulation strategies. Timepoint: Pretest, Posttest, Follow up. Method of measurement: Cognitive Emotion Regulation Questionnaire ( CERQ).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIran Davoudi Ph.D

Shahid Chamran University of Ahvaz

davoudi_iscu.ac.ir+98 61 1333 0011

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026